BURWIG SUSAN E 4

What Happened

• Susan E. Burwig, Executive Vice President, Operations of Medpace Holdings, exercised stock options on Feb 13, 2026 to acquire 10,984 common shares at a strike price of $107.93 per share, for a total cash cost of $1,185,503. The filing also shows the corresponding derivative (the option) was converted/terminated (reported as a disposition of the derivative instrument at $0.00).
• This transaction is an option exercise (transaction code M). It represents an acquisition of shares by exercising previously granted options rather than an open-market purchase; no sale of the acquired shares was reported in this filing.

Key Details

• Transaction date: 2026-02-13; Filing date: 2026-02-17 (filed within the SEC’s 2-business-day window; appears timely).
• Shares acquired: 10,984 at $107.93 each; total cash paid ≈ $1,185,503.
• Derivative disposed: 10,984 option units reported disposed at $0.00 (reflects conversion/termination of the option upon exercise).
• Footnote: The option vested in full on February 28, 2020.
• Shares owned after transaction: Not specified in the provided summary — see the full Form 4 for current holdings.

Context

• For retail investors: an M-code exercise means the insider paid the option strike to convert options into actual shares. Because there’s no reported sale of the shares here, this is not a cashless exercise or immediate sell-off.
• Exercises reflect the insider converting granted compensation into equity; while purchases can be a bullish signal, exercises often reflect long-standing compensation vesting and do not necessarily indicate a new conviction.